U.S. markets open in 52 minutes
  • S&P Futures

    4,131.75
    -51.75 (-1.24%)
     
  • Dow Futures

    34,391.00
    -277.00 (-0.80%)
     
  • Nasdaq Futures

    13,097.50
    -259.25 (-1.94%)
     
  • Russell 2000 Futures

    2,155.60
    -54.00 (-2.44%)
     
  • Crude Oil

    64.06
    -0.86 (-1.32%)
     
  • Gold

    1,839.60
    +2.00 (+0.11%)
     
  • Silver

    27.52
    +0.05 (+0.17%)
     
  • EUR/USD

    1.2167
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    1.6080
    +0.0060 (+0.37%)
     
  • Vix

    22.25
    +5.56 (+33.31%)
     
  • GBP/USD

    1.4142
    +0.0021 (+0.15%)
     
  • USD/JPY

    108.5720
    -0.2690 (-0.25%)
     
  • BTC-USD

    55,098.98
    -3,088.18 (-5.31%)
     
  • CMC Crypto 200

    1,569.68
    +8.38 (+0.54%)
     
  • FTSE 100

    6,935.92
    -187.76 (-2.64%)
     
  • Nikkei 225

    28,608.59
    -909.71 (-3.08%)
     

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
Pacira Pharmaceuticals, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

CONTACT: Company Contact: Pacira BioSciences, Inc. Christian Pedetti (973) 254-4387 Christian.pedetti@pacira.com